Gw Henssler & Associates LTD Incyte Corp Transaction History

Gw Henssler & Associates LTD

  • $1.76 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 26, 2023
BUY
$70.23 - $86.01 $2,598 - $3,182
37 Added 1.09%
3,417 $246,000
Q3 2022

Nov 04, 2022
BUY
$66.18 - $82.86 $32,692 - $40,932
494 Added 17.12%
3,380 $225,000
Q2 2022

Aug 04, 2022
BUY
$66.18 - $83.18 $190,995 - $240,057
2,886 New
2,886 $219,000

Others Institutions Holding INCY

# of Institutions
645
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.7B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Gw Henssler & Associates LTD Portfolio

Follow Gw Henssler & Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw Henssler & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gw Henssler & Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email